← Open Payments lookup

MONIQUE JACKSON: Open Payments

NPI 1952338543 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,019 in 49 payments from 25 companies in 2025. Trend: 2023 $2,322 · 2024 $4,511 · 2025 $6,019

Food & beverage: $6,019
CompanyPaymentsAmount
Gilead Sciences, Inc.9$1,196
Janssen Pharmaceuticals, Inc7$690
Janssen Biotech, Inc.5$661
ViiV Healthcare Company3$365
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$363
Alexion Pharmaceuticals, Inc.2$253
CSL Behring2$225
Neurocrine BioSciences, Inc.1$167
Bayer Healthcare Pharmaceuticals Inc.1$145
Madrigal Pharmaceuticals1$135

Products named: INVEGA SUSTENNA, RYBREVANT, Yeztugo, CAPLYTA, Hizentra, INGREZZA, Kerendia, REZDIFFRA.

Industry payments across CA — which companies pay providers there.